Keywords: merz, completes, memantine, studies, alzheimer, co, germany

Merz completes memantine studies in Alzheimer's

Article | 04 November 1999

Merz + Co of Germany has completed two European Phase III trials ofmemantine, licensed from Neurobiological Technologies, in patients with Alzheimer's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merz +

Go to company listing